Cargando…

Implementation of mifepristone medical abortion in Canada: pilot and feasibility testing of a survey to assess facilitators and barriers

BACKGROUND: Direct primary care provision of first-trimester medical abortion could potentially address inequitable abortion access in Canada. However, when Health Canada approved the combination medication Mifegymiso® (mifepristone 200 mg/misoprostol 800 mcg) for medical abortion in July 2015, we h...

Descripción completa

Detalles Bibliográficos
Autores principales:	Devane, Courtney, Renner, Regina M., Munro, Sarah, Guilbert, Édith, Dunn, Sheila, Wagner, Marie-Soleil, Norman, Wendy V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6839244/ https://www.ncbi.nlm.nih.gov/pubmed/31720004 http://dx.doi.org/10.1186/s40814-019-0520-8

Ejemplares similares

Could implementation of mifepristone address Canada’s urban–rural abortion access disparity: a mixed-methods implementation study protocol
por: Norman, Wendy V, et al.
Publicado: (2019)

Telemedicine for First-Trimester Medical Abortion in Canada: Results of a 2019 Survey
por: Renner, Regina M., et al.
Publicado: (2023)

Dispensing mifepristone for medical abortion in Canada: Pharmacists’ experiences of the first year
por: Zusman, Enav Z., et al.
Publicado: (2023)

A Virtual Community of Practice to Support Physician Uptake of a Novel Abortion Practice: Mixed Methods Case Study
por: Dunn, Sheila, et al.
Publicado: (2022)

Pharmacist dispensing of the abortion pill in Canada: Diffusion of Innovation meets integrated knowledge translation
por: Munro, Sarah, et al.
Publicado: (2021)

Pharmacist direct dispensing of mifepristone for medication abortion in Canada: a survey of community pharmacists
por: Zusman, Enav Z, et al.
Publicado: (2022)

Abortion services and providers in Canada in 2019: results of a national survey
por: Renner, Regina M., et al.
Publicado: (2022)

The perspective of Canadian health care professionals on abortion service during the COVID-19 pandemic
por: Ennis, Madeleine, et al.
Publicado: (2021)

Development and pilot testing of the 2019 Canadian Abortion Provider Survey
por: Renner, Regina M., et al.
Publicado: (2023)

Pharmacist checklist and resource guide for mifepristone medical abortion: User-centred development and testing
por: Rebic, Nevena, et al.
Publicado: (2021)

First trimester medication abortion practice in the United States and Canada
por: Jones, Heidi E., et al.
Publicado: (2017)

Leadership for success in transforming medical abortion policy in Canada
por: Dineley, Brigid, et al.
Publicado: (2020)

Medication Abortion With Pharmacist Dispensing of Mifepristone
por: Grossman, Daniel, et al.
Publicado: (2021)

POSTER ABSTRACTS: P5 IMPACT OF THE COVID-19 PANDEMIC ON ABORTION SERVICES: PROVIDER PERSPECTIVES
por: Wahl, K, et al.
Publicado: (2021)

Barriers and enablers to nurse practitioner implementation of medication abortion in Canada: A qualitative study
por: Carson, Andrea, et al.
Publicado: (2023)

Barriers to Rural Induced Abortion Services in Canada: Findings of the British Columbia Abortion Providers Survey (BCAPS)
por: Norman, Wendy V., et al.
Publicado: (2013)

The future of abortion is now: Mifepristone by mail and in-clinic abortion access in the United States
por: Mark, Alice, et al.
Publicado: (2021)

Implementing medical abortion with mifepristone and misoprostol in Norway 1998–2013
por: Løkeland, Mette, et al.
Publicado: (2017)

The use of mifepristone in abortion associated with an increased risk of uterine leiomyomas
por: Shen, Qi, et al.
Publicado: (2017)

Comparing telemedicine to in-clinic medication abortions induced with mifepristone and misoprostol
por: Wiebe, Ellen R, et al.
Publicado: (2020)

Mifepristone Antagonization with Progesterone to Avert Medication Abortion: A Scoping Review
por: DeBeasi, Paul L. C.
Publicado: (2023)

A more accurate approach to define abortion cohorts using linked administrative data: an application to Ontario, Canada
por: Schummers, Laura, et al.
Publicado: (2022)

Medical abortion with mifepristone and home administration of misoprostol up to 63 days’ gestation
por: Løkeland, Mette, et al.
Publicado: (2014)

Early medical abortion with self‐administered low‐dose mifepristone in combination with misoprostol
por: Song, Li‐Ping, et al.
Publicado: (2018)

Clinical Efficacy and Safety Study of Mifepristone with Misoprostol Treatment in Patients with Missed Abortion
por: Zhao, Xiaoying, et al.
Publicado: (2021)

The Perspective of Rural Physicians Providing Abortion in Canada: Qualitative Findings of the BC Abortion Providers Survey (BCAPS)
por: Dressler, Jennifer, et al.
Publicado: (2013)

Subsequent placenta accreta after previous mifepristone-induced abortion: A case report
por: Zhao, Peng, et al.
Publicado: (2021)

The efficacy and influence factors analysis of Mifepristone combined with estrogen-progesterone in the treatment of incomplete abortion
por: Wang, Kai, et al.
Publicado: (2022)

Retracted: Clinical Efficacy and Safety Study of Mifepristone with Misoprostol Treatment in Patients with Missed Abortion
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023)

Feasibility and Acceptability of a Mobile Technology Intervention to Support Postabortion Care (The FACTS Study Phase II) After Surgical Abortion: User-Centered Design
por: Gill, Roopan Kaur, et al.
Publicado: (2019)

Determination of Mifepristone (RU-486) and Its Metabolites in Maternal Blood Sample after Pharmacological Abortion
por: Szpot, Paweł, et al.
Publicado: (2022)

Trends in medication abortion and the role of low-volume and nonmetropolitan mifepristone purchasers: 2008–2011 and 2014–2017()
por: Jones, Rachel K.
Publicado: (2020)

Cost of goods sold analysis and recommendations to reduce costs of co-packaged mifepristone–misoprostol for medical abortion
por: Chinery, Lester, et al.
Publicado: (2020)

Mifepristone-Induced Hypothyroidism
por: Kalara, Niketa, et al.
Publicado: (2023)

A Retrospective Cost-Effectiveness Analysis of Mifepristone–Misoprostol Medical Abortions in the First Year at the Regina General Hospital
por: Hunter, Caitlin, et al.
Publicado: (2021)

A Longitudinal Cohort Study of Emergency Room Utilization Following Mifepristone Chemical and Surgical Abortions, 1999–2015
por: Studnicki, James, et al.
Publicado: (2021)

EXPRESSION OF CONCERN: A Longitudinal Cohort Study of Emergency Room Utilization Following Mifepristone Chemical and Surgical Abortions
Publicado: (2023)

Clinical Outcomes and Women’s Experiences before and after the Introduction of Mifepristone into Second-Trimester Medical Abortion Services in South Africa
por: Constant, Deborah, et al.
Publicado: (2016)

Comparison of mifepristone plus misoprostol with misoprostol alone for first trimester medical abortion: A systematic review and meta-analysis
por: Shimels, Tariku, et al.
Publicado: (2023)

Barriers to and facilitators of accessing HIV services for street-involved youth in Canada and Kenya
por: Khan, Momina, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_pn65l7h8gvspt7mbq1cosgmfeu